HNN3.0

Project cooperationUpdated on 16 January 2026

Seeking In Silico Modelling for Nanofiber-Based Cancer "Ecological Traps"

Strategy & Research Associate at Migration Biotherapeutics

Cambridge, United Kingdom

About

Migration Biotherapeutics is a UK-based start-up developing the ALIGHT device, a first-in-class "ecological trap" for Glioblastoma (GBM). Our technology utilises electrospun PCL nanofibers to physically redirect invasive tumour cells through contact guidance, preventing infiltration into healthy brain tissue.

For the HORIZON-MISS-2026-02-CANCER-01 call, we are seeking university-based research partners with expertise in in-silico computational modelling and Virtual Human Twin (VHT) development. We aim to create predictive digital models of our device’s physical steering mechanisms to accelerate R&D and provide performance data for First-in-Human trials. This collaboration will help validate the device's efficacy in a virtual environment, significantly de-risking the clinical translation process.

Similar opportunities